WAS
BSX icon

WESPAC Advisors SoCal’s Boston Scientific BSX Stock Holding History

WESPAC Advisors SoCal’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$7K – 113
2019
Q1 		$7K Hold
200
– – ﹤0.01% 259
2018
Q4 		$7K Hold
200
– – ﹤0.01% 262
2018
Q3 		$7K Buy
+200
New +$6.99K ﹤0.01% 253
2018
Q2 		– Sell
-200
Closed -$5K – 113
2018
Q1 		$5K Buy
+200
New +$5.44K ﹤0.01% 219

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

WESPAC Advisors SoCal's BSX Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 200 shares — an estimated $7K sold.

WESPAC Advisors SoCal first reported a position in BSX in Q1 2018 and held it in 4 quarters. The position peaked at $7K in Q1 2019. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 200 Boston Scientific shares in Q2 2019, an estimated $7K.
  • WESPAC Advisors SoCal first reported a position in Boston Scientific in Q1 2018 and held it in 4 quarters.
  • WESPAC Advisors SoCal's Boston Scientific position peaked at $7K in Q1 2019.
  • 757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.